Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study

OBJECTIVE: Patients with immune‐mediated diseases treated with anti‐CD20 monoclonal antibodies may have worse coronavirus disease 2019 (COVID‐19) outcomes due to impaired humoral immunity, but differences compared with the general population are unknown. METHODS: We identified patients with immune‐m...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Naomi J., D'Silva, Kristin M., Hsu, Tiffany Y‐T., DiIorio, Michael, Fu, Xiaoqing, Cook, Claire, Prisco, Lauren, Martin, Lily, Vanni, Kathleen M. M., Zaccardelli, Alessandra, Zhang, Yuqing, Sparks, Jeffrey A., Wallace, Zachary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916578/
https://www.ncbi.nlm.nih.gov/pubmed/34890478
http://dx.doi.org/10.1002/acr2.11386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916578/
https://www.ncbi.nlm.nih.gov/pubmed/34890478
http://dx.doi.org/10.1002/acr2.11386

Ejemplares similares